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We briefly summarized the Comprehensive Registry of Esophageal Cancer in Japan, 2012. Japanese Classification of Esophageal Cancer 10th [1] and UICC TNM Classification 7th [2] were used for cancer staging according to the subjected year. A total of 8003 cases were registered from 316 institutions in Japan. Tumor locations were cervical: 4.6%, upper thoracic: 12.8%, middle thoracic: 47.9%, lower thoracic: 26.1% and EG junction: 7.6%. Superficial carcinomas (Tis, T1a, T1b) were 38.2%. As for the histologic type of biopsy specimens, squamous cell carcinoma and adenocarcinoma accounted for 89.5% and 6.0%, respectively. Regarding clinical results, the 5-year survival rates of patients treated using endoscopic resection, concurrent chemoradiotherapy, radiotherapy alone, or esophagectomy were 84.4, 32.4, 24.9, and 55.6%, respectively. The endoscopic submucosal dissection accounted for 84.9% of endoscopic resection. Esophagectomy was performed in 4722 cases. Concerning the approach used for esophagectomy, 36.0% of the cases were treated thoracoscopically. The operative mortality (within 30 days after surgery) was 0.52% and the hospital mortality was 2.35%. The 5-year survival rate of patients with pStage IV in UICC classification (including patients with supraclavicular node metastasis) was better than that of patients with pStage IVb in JES classification (not including patients with supraclavicular node metastasis).
We hope that this Comprehensive Registry of Esophageal Cancer in Japan for 2012 will help to improve all aspects of the diagnosis and treatment of esophageal cancer in Japan. Table 1 Age and gender - Table 2 Primary treatment - Table 3 Tumor location - Table 4 Histologic types of biopsy specimens - Table 5 Depth of tumor invasion, cT (UICC TNM 7th) - Table 6 Lymph node metastasis, cN (UICC TNM 7th) - Table 7 Distant metastasis, cM (UICC TNM 7th) - Table 8 Clinical stage (UICC TNM 7th) II. Results of endoscopically treated patients in 2012 Table 9 Details of endoscopic treatment for curative intent  Table 10 Complications of EMR/ESD  Table 11 IV. Results in patients who underwent esophagectomy in 2012   Table 14 Treatment modalities of esophagectomy  Table 15 Tumor location  Table 16 Approaches to tumor resection  Table 17 Video-assisted surgery  Table 18 Fields of lymph node dissection according  to the location of the tumor  Table 19 Reconstruction route  Table 20 Organs used for reconstruction  Table 21 Histological classification  Table 22 Depth of tumor invasion, pT (JES 10th) Table 23 Pathological grading of lymph node metastasis, pN (JES 10th) Table 24 Pathological findings of lymph node metastasis, pN (UICC 7th) Table 25 Pathological findings of distant organ metastasis, pM (JES 10th) Table 26 Residual tumor  Table 27 Causes of death Tables 1, 2 , 3, 4, 5, 6, 7, 8. 
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II. Results of endoscopically treated patients in 2012
Tables 9, 10, 11 and Figs. 1, 2, 3. Lower thoracic 
